FR2733500B1 - Nouveaux antisens diriges contre ras, preparation et utilisations - Google Patents
Nouveaux antisens diriges contre ras, preparation et utilisationsInfo
- Publication number
- FR2733500B1 FR2733500B1 FR9505165A FR9505165A FR2733500B1 FR 2733500 B1 FR2733500 B1 FR 2733500B1 FR 9505165 A FR9505165 A FR 9505165A FR 9505165 A FR9505165 A FR 9505165A FR 2733500 B1 FR2733500 B1 FR 2733500B1
- Authority
- FR
- France
- Prior art keywords
- antisens
- novel
- preparation
- directed against
- against ras
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3511—Conjugate intercalating or cleaving agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3527—Other alkyl chain
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9505165A FR2733500B1 (fr) | 1995-04-28 | 1995-04-28 | Nouveaux antisens diriges contre ras, preparation et utilisations |
PCT/FR1996/000652 WO1996034008A1 (fr) | 1995-04-28 | 1996-04-29 | Nouveaux antisens diriges contre ras, preparation et utilisations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9505165A FR2733500B1 (fr) | 1995-04-28 | 1995-04-28 | Nouveaux antisens diriges contre ras, preparation et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2733500A1 FR2733500A1 (fr) | 1996-10-31 |
FR2733500B1 true FR2733500B1 (fr) | 1997-07-25 |
Family
ID=9478568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9505165A Expired - Lifetime FR2733500B1 (fr) | 1995-04-28 | 1995-04-28 | Nouveaux antisens diriges contre ras, preparation et utilisations |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2733500B1 (fr) |
WO (1) | WO1996034008A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339066B1 (en) | 1990-01-11 | 2002-01-15 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
US6537973B1 (en) | 1992-03-16 | 2003-03-25 | Isis Pharmaceuticals, Inc. | Oligonucleotide inhibition of protein kinase C |
US5985558A (en) | 1997-04-14 | 1999-11-16 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos |
WO1999001579A1 (fr) | 1997-07-01 | 1999-01-14 | Isis Pharmaceuticals, Inc. | Compositions et procedes d'apport d'oligonucleotides par le tube digestif |
US6809193B2 (en) | 1997-08-13 | 2004-10-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
US6133246A (en) * | 1997-08-13 | 2000-10-17 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
US5877309A (en) * | 1997-08-13 | 1999-03-02 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides against JNK |
EP2057284A4 (fr) | 2006-08-04 | 2011-06-29 | Isis Pharmaceuticals Inc | Compositions et procédés de modulation de protéines jnk |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002534A2 (fr) * | 1990-08-03 | 1992-02-20 | Sterling Drug, Inc. | Composes et procedes d'inhibition de l'expression de genes |
WO1994008003A1 (fr) * | 1991-06-14 | 1994-04-14 | Isis Pharmaceuticals, Inc. | INHIBITION DU GENE ras A L'AIDE D'OLIGONUCLEOTIDES NON CODANTS |
AU6633694A (en) * | 1993-04-09 | 1994-11-08 | Board Of Regents Of The University Of Nebraska, The | Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides |
CA2129565A1 (fr) * | 1993-08-06 | 1995-02-07 | Hiroshi Tanimura | Composes oligonucleotides, leur production et leur utilisation |
-
1995
- 1995-04-28 FR FR9505165A patent/FR2733500B1/fr not_active Expired - Lifetime
-
1996
- 1996-04-29 WO PCT/FR1996/000652 patent/WO1996034008A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996034008A1 (fr) | 1996-10-31 |
FR2733500A1 (fr) | 1996-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961160D0 (no) | Cykliske forbindelser, deres fremstilling og anvendelse | |
FI950715A0 (fi) | Ytmikromekanisk, symmetrisk tryckskillnadsgivare | |
KR970010798A (ko) | 프로필렌-에틸렌 랜덤 공중합체, 이의 제조방법 및 이의 필름 | |
ATE299135T1 (de) | Hydroxypyridinone | |
KR970002039A (ko) | 급속발효 사료와 그 제조방법 및 용도 | |
DK0822943T3 (da) | Inulinderivater | |
NO960499D0 (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
FR2733500B1 (fr) | Nouveaux antisens diriges contre ras, preparation et utilisations | |
TR28331A (tr) | 13-ikameli milbemisin türevleri, bunlarin hazirlanmalari ve kullanimlari. | |
DK0874814T3 (da) | 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler | |
DE69613074T2 (de) | Pasteureinrichtung | |
DE69603159T2 (de) | Fluorierte ionenaustauschpolymere, sowie zwischenprodukten dazu | |
FI965064A (fi) | Veteenliukeneva suurimolekyylinen yhdiste, joka sisältää silikonia ja sen tuotanto ja käyttö | |
BR9610193A (pt) | 4-Tiocarbamoil-1-(2-Pirazolil)-pirazóis | |
FR2750134B1 (fr) | 1-c-perfluoroalkyl glycosides, procede de preparation et utilisations | |
FR2740776B1 (fr) | Polyurethannes, leur preparation et leurs utilisations | |
FR2734826B1 (fr) | Deltap62, ses variants, sequences nucleiques et leurs utilisations | |
KR970000080A (ko) | 김양념 조미액 및 그 제조방법 | |
ES1032571Y (es) | Gafa, | |
KR970016941U (ko) | 흙파기차용 전, 후진 변속기 | |
KR970006960U (ko) | 해금, 주아의 구조 | |
FI950352A0 (fi) | Vaermeisolerad takkonstruktion, foerfarande foer vaermeisolering av takkonstruktionen och fogkonstruktion av vaermeisoleringsskivor | |
TR199600103A2 (tr) | Tienopirimidin türevleri, üretimi ve kullanimi. | |
DE59605931D1 (de) | Zufallszahlengeber | |
ES1032087Y (es) | Perfeccionamientos introducidos en puertas seccionales. |